Tanner Pharma Group

How did we source 165 packs of comparator cardiology products across three EU markets through a single supply chain, provide GDP-compliant interim storage, and deliver them to India, all within a strict three-week timeline? We just…did. After 25 years, multi-country sourcing, import documentation, global logistics, and coordinated delivery are second nature to us. Regulatory complexity, tight timelines, and strict temperature-control requirements are challenges we navigate every day. We get it done compliantly and on time. Every time. We have the expertise, but we also have the people. And they make all the difference.   Read the full case study: https://lnkd.in/eFPM6AWn

We could talk about how good we are at managing timelines, multi-country regulatory landscapes, or even global logistics. Technically, we just did. But what we like to brag about most is our ability to connect product to patient. Continuity of care: 10/10

We're #hiring a new Pharmacy Account Manager in United Kingdom. Apply today or share this post with your network.

If it’s not "AI", it’s "speed, agility, and efficiency." We’re hearing these words come up more and more across industry conversations. But how can biotechs and CROs act on them? The answer is partnership. Specifically, partnership with a clinical trial services provider who can: -         Deliver on tight timelines -         Execute on the complex regulatory landscape -         Build agility into their strategy rather than relying on reactive flexibility The beauty of partnership is shared knowledge. You focus on creating a practical protocol, and we’ll focus on supporting protocol execution with speed, agility, and efficiency. Learn more about how we do it: https://lnkd.in/es-tK4V7

We're #hiring a new Temporary MAP Customer Advocate (Full-Time, 3–6 Month Assignment) in Charlotte, North Carolina. Apply today or share this post with your network.

We're #hiring a new Pharmaceuticals Customer Service in Cork, County Cork. Apply today or share this post with your network.

We asked our team to take pictures of their experience at BIO US in San Diego…this is what we got back. All jokes aside, our team had a blast networking with partners at the BIO US conference and across the greater San Diego area. Cheers to partnership ⚾👏

Now that post-trial supply access for patients is a mandatory implementation following amendments to the Declaration of Helsinki, we thought we’d share an example of Tanner’s expertise on the matter. Here’s the situation: A US pharmaceutical company with a portfolio of oncology products completed a phase 3 study for monotherapy treatment of a rare kidney cancer. While the trial failed to meet its primary endpoint in the study, some patients were still responding to treatment. The studied drug already had US FDA and EMA approval in another indication, and the company wanted to support trial patients wishing to continue with treatment. With trial sites in Europe and Latin America, the company had out-licensed commercial rights for the product in the approved indication to a commercial partner for Europe but had retained the rights for Latin America. 👉 Tanner’s value: We worked with the company to identify the regulatory pathways that would need to be followed in each country, including submission of a post-trial access protocol in Brazil. For each investigator that expressed interest in continuing treatment for patients, Tanner supported the site with navigating the regulatory pathway for access. For sites in Latin America, Tanner sourced US-labeled products from the company in the US. For sites in Europe, Tanner purchased commercial product from the company's European partner, stored the product at a Tanner warehouse in Germany, and labeled product to comply with local regulatory requirements. And there’s more where that came from. Learn more about our Post-Trial Supply solutions at https://lnkd.in/ehKP-pbC